Ready-To-Use Panels Fulfill CLIA’s Performance Specifications for Assay Verification
Posted on 13 Sep 2023
LGC Clinical Diagnostics (Middlesex, UK) - SeraCare (Milford, MA, USA) has launched its AccuSet HIV Verification Panels - ready-to-use panels designed to fulfill ISO and CLIA’s Performance Specifications for assay verification.
The AccuSet HIV Verification Panels are a great tool to help install a new HIV test method and perform assay verification, as well as help evaluate assay performance during development, performing assay validation, and troubleshoot test methods. These panels consist of naturally occurring plasma samples that perfectly mimic patient specimens on laboratory instrumentation. The panels include highly characterized mixed-titer samples that will allow users to efficiently onboard their new assays.
The company offers two HIV Verification Panels to provide labs with options for onboarding both molecular and serological HIV assays based on their specific verification requirements. With the choice of one or both verification panels, labs can tailor their selection to match specific verification protocols. The AccuSet HIV Verification Panels provide the tools labs need to easily meet CLIA’s performance specifications so that users can verify their test system and start reporting patient results.